13 Results for "

curcumin derivative

" in MedChemExpress (MCE) Product Catalog:
Products (13)

13 Results for "curcumin derivative" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-N0007
CAS No.: 33171-05-0
Synonyms: (E,E)-curcumin III; (E,E)-Didemethoxycurcumin
(E,E)-Bisdemethoxycurcumin ((E,E)-Curcumin III) is a curcumin derivative with anti-inflammatory and anticancer activities .
loading...
    loading...
Cat. No.: HY-100977
CAS No.: 160096-59-3
Purity:  98.89%
Synonyms: DiMC; CHC 004; Di-O-methylcurcumin
Target:  

NO Synthase NF-κB

Research Areas:  

Inflammation/Immunology

Dimethoxycurcumin is a derivative of curcumin that has anti-inflammatory and antioxidant activities .
loading...
    loading...
Cat. No.: HY-137315
CAS No.: 1462868-88-7
Purity:  99.01%
Research Areas:  

Neurological Disease

TML-6, an orally active curcumin derivative, inhibits the synthesis of the β-amyloid precursor protein and β-amyloid (Aβ). TML-6 can upregulate Apo E, suppress NF-κB and mTOR, and increase the activity of the anti-oxidative Nrf2 gene. TML-6 has the potential for Alzheimer’s disease (AD) research .
loading...
    loading...
Cat. No.: HY-179228
CAS No.: 1246964-08-8
Target:  

CTLA-4 TGF-beta/Smad

Research Areas:  

Cancer

AN02 is a derivative of Curcumin (HY-N0005). AN02 inhibits the proliferation and clonogenicity, migration and invasion of ovarian cancer cells. AN02 dose-dependently upregulates the expression of APC and mediates the degradation of CTLA-4 through SMAD4. In the small xenograft model, AN02 significantly inhibits tumor growth and reverses the tumor immune-suppressive microenvironment. AN02, when combined with Ipilimumab (HY-P9901), can enhance efficacy and inhibit epithelial-mesenchymal transition. AN02 can be used for the study of ovarian cancer .
loading...
    loading...
Cat. No.: HY-N0894R
CAS No.: 36062-07-4
Synonyms: Hexahydrobisdemethoxycurcumin (Standard)
Octahydrocurcumin (Hexahydrobisdemethoxycurcumin) is a hydrogenated derivative of curcumin and a metabolite of curcumin. Octahydrocurcumin is an orally active anticancer and anti-inflammatory agent, and is the final hydrogenated metabolite of Curcumin (HY-N0005) in vivo. Octahydrocurcumin exerts its anti-tumor and anti-inflammatory effects by inducing the mitochondrial apoptosis pathway and inhibiting the TAK1-NF-κB-COX-2 pathway, respectively .
loading...
    loading...
Cat. No.: HY-N0007R
CAS No.: 33171-05-0
Synonyms: (E,E)-curcumin III (Standard); (E,E)-Didemethoxycurcumin (Standard)
(E,E)-Bisdemethoxycurcumin (Standard) is the analytical standard of (E,E)-Bisdemethoxycurcumin. This product is intended for research and analytical applications. (E,E)-Bisdemethoxycurcumin ((E,E)-Curcumin III) is a curcumin derivative with anti-inflammatory and anticancer activities .
loading...
    loading...
Cat. No.: HY-137315S
CAS No.: 2673270-28-3
TML-6-d3 is the deuterium labeled TML-6. TML-6, an orally active curcumin derivative, inhibits the synthesis of the β-amyloid precursor protein and β-amyloid (Aβ). TML-6 can upregulate Apo E, suppress NF-κB and mTOR, and increase the activity of the anti-
loading...
    loading...
Cat. No.: HY-15668
CAS No.: 1370037-59-4
Research Areas:  

Cancer

ST09 is an efficient and low toxicity Curcumin (HY-N0005) derivative. ST09 significantly inhibits cell migration and downregulates the expression of MMP1, MMP2, and Vimentin. ST09 has strong cytotoxicity to breast cancer cells, such as MDA-MB-231, MCF7 and T47D cells. ST09 induces cell apoptosis by upregulating Bax and cleaved caspase-3/9. ST09 can be used in the research of cancer such as breast cancer .
loading...
    loading...
Cat. No.: HY-151342
CAS No.: 3032193-12-4
Target:  

Drug Derivative

Research Areas:  

Others

Ser@TPP@CUR is a Curcumin (HY-N0005) derivative. Ser@TPP@CUR effectively ameliorates injured renal tubular epithelial cells and improves renal functions of acute kidney injury (AKI) mice. Ser@TPP@CUR can be used for the research of AKI .
loading...
    loading...
Cat. No.: HY-120914
CAS No.: 170950-29-5
Synonyms: GO-Y015
Target:  

TrxR Apoptosis

Research Areas:  

Cancer

TrxR1-IN-B19 (GO-Y015) (Compound B19) is a Curcumin (HY-N0005) derivative and colvalent TrxR1 inhibitor. TrxR1-IN-B19 inhibits TrxR1 enzyme activity to elevate oxidative stress, and then induce ROS-mediated ER Stress and mitochondrial dysfunction, subsequently resulting in cell cycle arrest and apoptosis .
loading...
    loading...
Cat. No.: HY-N12669
CAS No.: 387818-26-0
Curcumin monoglucoside is a flavonoid derivative possessing antioxidant, anti-apoptotic, neuroprotective effects, and antibacterial activity. Curcumin monoglucoside can be used in research on Parkinson's disease.
loading...
    loading...
Cat. No.: HY-100977S
CAS No.: 3006902-95-7
Synonyms: DiMC-d6; CHC 004-d6; Di-O-methylcurcumin-d6
Dimethoxycurcumin-d6 is the deuterium labeled Dimethoxycurcumin (HY-100977). Dimethoxycurcumin is a derivative of Curcumin that has anti-inflammatory and antioxidant activities .
loading...
    loading...
Cat. No.: HY-139804
CAS No.: 1297262-16-8
CTK7A is a curcumin derivative with anticancer activity by inhibiting the HAT activity of p300 and reducing the autoacetylation of p300, thereby affecting its interaction with HIF-1α. The inhibition of CTK7A leads to decreased HIF-1α accumulation and activity, which can be used for cancer research .
loading...
    loading...
  • 1